GlassScriptPhysician profile
James V Rider
NPI 1215968870
$81,016.67
in general payments reported to CMS, 2019-2025
57 companies · $2,336 in 2025
The $2,336 reported for 2025 was more than what 96% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $4,104 · 2021: $19K · 2022: $1,234 · 2023: $1,649 · 2024: $1,828 · 2025: $2,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,277 · Education: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,277.39 |
| Education | $534.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $70,613.89 | 2019-2021 | |
| Organogenesis INC. | $1,876.24 | 2019-2024 | Puraply Wound Matrix, Affinity, Puraply |
| Sunovion Pharmaceuticals INC. | $793.23 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $786.68 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $683.39 | 2019-2025 | Ingrezza |
| Kerecis Limited | $592.39 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| E.R. Squibb & Sons, L.L.C. | $496.83 | 2019-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $457.24 | 2019-2025 | Fanapt, Hetlioz |
| Abbvie INC. | $349.97 | 2021-2025 | |
| Ucb, INC. | $333.36 | 2023-2024 | Nayzilam, Briviact |
| Otsuka America Pharmaceutical, INC. | $322.50 | 2022-2025 | Rexulti, Nuedexta, Abilify Asimtufii |
| Acadia Pharmaceuticals INC | $312.97 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $291.85 | 2019-2025 | Invega Sustenna |
| Eisai INC. | $273.81 | 2019-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $248.82 | 2021-2025 | Caplyta |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $221.44 | 2023-2024 | Aptiom, Gemtesa |
| Axsome Therapeutics, INC. | $191.48 | 2024 | Auvelity |
| Lundbeck LLC | $183.93 | 2023-2025 | Rexulti |
| Amgen INC. | $152.18 | 2019-2025 | Otezla, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $146.63 | 2019-2022 | |
| Corium, LLC | $99.93 | 2022-2023 | Adlarity |
| Hydrofera LLC | $95.27 | 2023-2025 | Hydrofera Blue |
| Alkermes, INC. | $89.43 | 2022-2025 | Aristada, Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $87.23 | 2021-2022 | |
| Urgo Medical North America, LLC | $72.52 | 2022 | |
| Medline Industries LP | $68.71 | 2024 | Medline |
| Smith+Nephew, INC. | $68.13 | 2020-2024 | Allevyn Gentle Border Lite 10cm X 10cm, Allevyn Life L 15.4x15.4 Ctn10, Collagenase Santyl |
| Glaxosmithkline, LLC. | $65.56 | 2021-2024 | Shingrix, Arexvy |
| 3m Company | $63.89 | 2019 | |
| Pfizer INC. | $63.09 | 2019-2023 | |
| Next Science LLC | $62.06 | 2023 | Surgx, Blastx, Xperience |
| Viatris Specialty LLC | $60.79 | 2025 | Yupelri |
| Kyowa Kirin, INC. | $60.47 | 2021-2022 | |
| Coloplast Corp | $59.36 | 2024 | |
| Novo Nordisk INC | $58.99 | 2019-2023 | Wegovy |
| Aroa Biosurgery Incorporated | $51.71 | 2019-2023 | |
| Melinta Therapeutics, LLC | $50.61 | 2024 | Kimyrsa, Orbactiv, Rezzayo |
| Sk Life Science, INC. | $46.82 | 2023-2024 | |
| Scilex Pharmaceuticals INC. | $38.45 | 2022-2024 | |
| Solventum Corporation | $37.24 | 2024 | Promogran Prisma, Activ.A.C. |
| Tei Medical INC. | $36.94 | 2019 | |
| Avanir Pharmaceuticals, INC. | $33.65 | 2019 | |
| Mylan Specialty L.P. | $33.38 | 2024 | Yupelri |
| Verona Pharma, INC. | $32.27 | 2025 | Ohtuvayre |
| Integra Lifesciences Corporation | $28.70 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lilly USA, LLC | $27.28 | 2021-2023 | Trulicity, Baqsimi |
| Nestle Healthcare Nutrition INC. | $24.00 | 2022 | |
| Jazz Pharmaceuticals INC. | $22.77 | 2025 | |
| Aimmune Therapeutics, INC. | $19.97 | 2025 | Zenpep |
| Amarin Pharma, INC. | $17.69 | 2021 | |
| Allergan, INC. | $17.34 | 2019 | |
| Reprise Biomedical, INC. | $16.97 | 2025 | Miro3d |
| Biogen, INC. | $16.92 | 2022 | |
| Abbott Laboratories | $15.85 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.68 | 2022 | |
| Kci USA, INC. | $14.66 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.51 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.